Correlation Between Catalyst Pharmaceuticals and Radcom

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Radcom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Radcom into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and Radcom, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Radcom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Radcom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Radcom.

Diversification Opportunities for Catalyst Pharmaceuticals and Radcom

0.14

Correlation Coefficient

Catalyst Pharmaceuticals  Radcom

Average diversification

The 3 months correlation between Catalyst and Radcom is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Radcom in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Radcom and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Radcom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Radcom has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Radcom go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Radcom

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 2.43 times less return on investment than Radcom. In addition to that, Catalyst Pharmaceuticals is 1.04 times more volatile than Radcom. It trades about 0.05 of its total potential returns per unit of risk. Radcom is currently generating about 0.13 per unit of volatility. If you would invest  1,204  in Radcom on October 26, 2024 and sell it today you would earn a total of  120.50  from holding Radcom or generate 10.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  Radcom

Catalyst Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Catalyst Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Radcom

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Radcom are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Radcom displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Catalyst Pharmaceuticals and Radcom

The main advantage of trading using opposite Catalyst Pharmaceuticals and Radcom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Radcom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Radcom will offset losses from the drop in Radcom's long position.

The idea behind Catalyst Pharmaceuticals and Radcom pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.